{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:15:58Z","timestamp":1773015358022,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Human immunodeficiency virus (HIV) infection increases the risk of thrombotic microangiopathy (TMA), but TMA in the setting of HIV infection is not well characterized. The experience with TMA in the setting of HIV infection at the University of Maryland Medical Center was reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design and methods<\/jats:title><jats:p>Patients undergoing therapeutic plasma exchange (TPE) for TMA from January 1, 2000 through December 31, 2012 were reviewed. Those with known HIV\u2010positive and \u2010negative status were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 102 patients with known HIV status, 28 (27%) were HIV\u2010positive, including 3 with previously undiagnosed HIV. HIV\u2010positive patients had a median viral load of 89 500 copies\/mL (range, 0\u2010&gt;750 000 copies\/mL) and a median CD4 count of 58 cells\/\u00b5L (range, 2\u2010410 cells\/\u00b5L). Compared to HIV\u2010negative patients, HIV\u2010positive patients more frequently presented with concurrent infections (60.7% vs. 23.7%; <jats:italic>P<\/jats:italic>\u2009=\u2009.0007), had a trend toward lower median platelet counts (3000\/\u00b5L vs. 15 000\/\u00b5L; <jats:italic>P<\/jats:italic>\u2009=\u2009.07) and more frequently had platelet counts less than 10 000\/mcL (<jats:italic>P<\/jats:italic>\u2009=\u2009.02). Nevertheless, number of TPE procedures required for remission, remission rate, mortality, and relapse incidence were similar in HIV\u2010positive and HIV\u2010negative patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The incidence described herein of HIV infection among TMA patients is the highest reported outside of South Africa. More severe thrombocytopenia in HIV\u2010positive patients may reflect TMA in the setting of preexisting HIV\u2010associated thrombocytopenia. HIV should be considered in patients with TMA, and TMA should be considered in HIV\u2010positive patients with severe thrombocytopenia.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jca.21615","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T17:33:24Z","timestamp":1516988004000},"page":"342-348","source":"Crossref","is-referenced-by-count":9,"title":["Thrombotic microangiopathy in the setting of human immunodeficiency virus infection: High incidence of severe thrombocytopenia"],"prefix":"10.1002","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4002-0749","authenticated-orcid":false,"given":"Najeebah A.","family":"Bade","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland, 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria S.","family":"Giffi","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland, 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Baer","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland, 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann B.","family":"Zimrin","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland, 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie Y.","family":"Law","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland, 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland, School of Medicine 22 South Greene Street, Baltimore Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0476-1"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0193"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196603000-00003"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-271445"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01436.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24612"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp053024"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.idc.0000121025.62151.80"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450407"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-3-194"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250315"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/597471"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830500203"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05325.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01346.x"},{"key":"e_1_2_7_18_1","unstructured":"Centers for Disease Control and Prevention.HIV Surveillance Report.2014; vol. 26.http:\/\/www.cdc.gov\/hiv\/library\/reports\/surveillance\/. Published February 2015."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10450"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12059"},{"issue":"8","key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1182\/blood.V80.8.1890.bloodjournal8081890","article-title":"Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic","volume":"80","author":"Thompson CE","year":"1992","journal-title":"Blood."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/422363"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2002.03349.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.3.360"},{"key":"e_1_2_7_25_1","first-page":"187","article-title":"Hematologic complications of HIV infection","volume":"7","author":"Sloand E.","year":"2005","journal-title":"AIDS Rev."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20176"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0313"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21470_c"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199709000-00004"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.3.350"},{"key":"e_1_2_7_31_1","first-page":"473","article-title":"Association between cytomegalovirus (CMV) infection and thrombotic microangiopathy (TMA) in HIV infected patients","volume":"6","author":"Peraldi MN","year":"1995","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f0e41a"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.21615","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:32:19Z","timestamp":1694993539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/jca.21615"],"URL":"https:\/\/doi.org\/10.1002\/jca.21615","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,26]]}}}